Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 22 IN SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride (KCl) dissociation yields potassium ions that maintain intracellular fluid volume, transmembrane electrochemical gradients, and action potentials in excitable tissues. It repletes potassium deficits and prevents hypokalemia. Sodium chloride provides sodium and chloride ions to maintain extracellular fluid osmolality and volume.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion. Adult dose: 10-20 mEq/hour of potassium chloride, typically administered in a concentration of 0.22% (which is 2 mEq/100 mL) in 0.9% sodium chloride. Rate should not exceed 10 mEq/hour for non-emergency situations; maximum daily dose is 200 mEq.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable as a drug; potassium homeostasis is tightly regulated. Serum potassium has a distribution half-life of ~1-1.5 h, with renal elimination half-life depending on glomerular filtration and tubular secretion, typically 6-8 h in normal renal function.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% as potassium ion; negligible biliary/fecal excretion under normal conditions.
Category C
Category A/B
Electrolyte
Electrolyte